SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (CAPR) (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today ...
Companies will be invited to sign up to the project. Signing up to the EU PFAS Consultation Project will provide companies with assurance that their product requirements and uses are met. Even though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback